In the heart of New Jersey sits ImClone Systems, a Biopharmaceutical company
committed to advancing oncology care through the development and manufacturing
of targeted biological treatments. The completion of this new 250,000
square foot GMP facility in Branchburg, NJ provides ImClone with the total
production capacity of 140,000 liters, the largest in the biotech industry.
This state-of-the-art manufacturing facility “Building BB50”,
received FDA approval for multiple products, allowing ImClone to scale-up
the production of ERBITUX® and their portfolio of novel, fully human
Binsky & Snyder was called upon to install the facility’s High
Pressure Steam Boiler Plant and Chilled Water Plant along with 125,000
feet of process and utility piping to serve the HVAC and Process Equipment.
At the project’s peak the 120 man crew installed 30” and smaller
diameter piping at a production rate of up to 20,000 feet per month.
The complicated 3D piping design required Binsky to have on-site model
operators and engineering staff to deliver the information to the field
for installation. Binsky's comprehensive isometric tracking system
and procedures made sure production rate was maintained at the required levels.
Full time quality control professionals worked with field and management
staff to ensure that installation and documentation exceeded the FDA validation
standards. The end result being Binsky & Snyder helped deliver a premier
Biotech Facility to ImClone.